Timothy E. Welty

1.5k total citations
53 papers, 1.1k citations indexed

About

Timothy E. Welty is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Timothy E. Welty has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pediatrics, Perinatology and Child Health, 28 papers in Psychiatry and Mental health and 8 papers in Pharmacology. Recurrent topics in Timothy E. Welty's work include Epilepsy research and treatment (27 papers), Pharmacological Effects and Toxicity Studies (23 papers) and Pharmaceutical studies and practices (14 papers). Timothy E. Welty is often cited by papers focused on Epilepsy research and treatment (27 papers), Pharmacological Effects and Toxicity Studies (23 papers) and Pharmaceutical studies and practices (14 papers). Timothy E. Welty collaborates with scholars based in United States, United Kingdom and China. Timothy E. Welty's co-authors include Michael Privitera, Mikiko Yamada, Barry E. Gidal, Marty L. Eng, Jean M. Nappi, Cory G Garvin, Paul P. Dobesh, Sarah A. Spinler, Joseph J. Saseen and John A. Bosso and has published in prestigious journals such as Neurology, The Lancet Neurology and Epilepsia.

In The Last Decade

Timothy E. Welty

50 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy E. Welty United States 17 421 346 224 214 170 53 1.1k
Michael E. Pitterle United States 22 428 1.0× 279 0.8× 324 1.4× 138 0.6× 97 0.6× 46 1.1k
Ida Fortino Italy 24 187 0.4× 312 0.9× 337 1.5× 116 0.5× 280 1.6× 108 1.9k
M. Feely United Kingdom 19 412 1.0× 361 1.0× 147 0.7× 117 0.5× 166 1.0× 40 1.2k
Geneviève Durrieu France 24 320 0.8× 191 0.6× 225 1.0× 97 0.5× 185 1.1× 105 1.7k
Reginald P. Sequeira Bahrain 17 284 0.7× 236 0.7× 231 1.0× 193 0.9× 35 0.2× 65 1.2k
Thilo Bertsche Germany 22 552 1.3× 376 1.1× 378 1.7× 89 0.4× 76 0.4× 133 1.3k
Branislava Miljković Serbia 18 260 0.6× 210 0.6× 164 0.7× 57 0.3× 87 0.5× 91 887
B.‐E. Wiholm Sweden 23 233 0.6× 113 0.3× 160 0.7× 236 1.1× 80 0.5× 35 1.7k
Leonardo Régis Leira Pereira Brazil 19 202 0.5× 116 0.3× 376 1.7× 81 0.4× 133 0.8× 134 1.2k
Jordan R. Covvey United States 18 155 0.4× 80 0.2× 149 0.7× 398 1.9× 79 0.5× 74 1.2k

Countries citing papers authored by Timothy E. Welty

Since Specialization
Citations

This map shows the geographic impact of Timothy E. Welty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy E. Welty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy E. Welty more than expected).

Fields of papers citing papers by Timothy E. Welty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy E. Welty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy E. Welty. The network helps show where Timothy E. Welty may publish in the future.

Co-authorship network of co-authors of Timothy E. Welty

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy E. Welty. A scholar is included among the top collaborators of Timothy E. Welty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy E. Welty. Timothy E. Welty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Welty, Timothy E., et al.. (2022). Guidelines for therapeutic interchange—2022. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5(4). 476–483. 1 indexed citations
2.
French, Jacqueline A., Emilio Perucca, Josemir W. Sander, et al.. (2021). FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force. Epilepsia Open. 6(1). 45–48. 47 indexed citations
3.
Welty, Timothy E., Barry E. Gidal, Michael Privitera, et al.. (2021). Coffee and cigarette smoking interactions with lamotrigine. Epilepsy & Behavior. 116. 107741–107741. 4 indexed citations
4.
Vossler, David G., Jacquelyn Bainbridge, Jane Boggs, et al.. (2020). Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee. Epiliepsy currents. 20(5). 245–264. 68 indexed citations
5.
Privitera, Michael, Timothy E. Welty, Barry E. Gidal, et al.. (2016). Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial. The Lancet Neurology. 15(4). 365–372. 73 indexed citations
6.
7.
Clay, Patrick G., W. Klugh Kennedy, Mary Jayne Kennedy, et al.. (2010). The Essential Research Curriculum for Doctor of Pharmacy Degree Programs. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(9). 966–966. 47 indexed citations
8.
Jiang, Qian, Gang Jiang, Timothy E. Welty, & Ming‐Hua Zheng. (2010). Naloxone in the management of hepatic encephalopathy. Journal of Clinical Pharmacy and Therapeutics. 35(3). 333–341. 11 indexed citations
9.
Welty, Timothy E., et al.. (2010). Effect of limited transportation on medication adherence in patients with epilepsy. Journal of the American Pharmacists Association. 50(6). 698–703. 26 indexed citations
10.
Griffith, H. Randall, Roy C. Martin, Stephanie Andrews, et al.. (2008). The safety and tolerability of galantamine in patients with epilepsy and memory difficulties. Epilepsy & Behavior. 13(2). 376–380. 14 indexed citations
11.
Welty, Timothy E.. (2007). Evidence-based Pharmacotherapy: Optimal Patient Care = Best Knowledge + Competent Practitioner. American Journal of Pharmaceutical Education. 71(6). 1 indexed citations
12.
Welty, Timothy E.. (2006). Juvenile Myoclonic Epilepsy. Pediatric Drugs. 8(5). 303–310. 16 indexed citations
13.
Welty, Timothy E., et al.. (2003). Point-of-Care Testing: An Introduction. Annals of Pharmacotherapy. 38(1). 119–125. 39 indexed citations
14.
Welty, Timothy E., Michael Privitera, & Rakesh Shukla. (1998). Increased Seizure Frequency Associated With Felbamate Withdrawal in Adults. Archives of Neurology. 55(5). 641–641. 7 indexed citations
15.
Privitera, Michael & Timothy E. Welty. (1996). Acute Phenytoin Toxicity Followed by Seizure Breakthrough From a Ticlopidine-Phenytoin Interaction. Archives of Neurology. 53(11). 1191–1192. 10 indexed citations
16.
Beardsley, John W., Douglas F. Covey, Anna Hume, et al.. (1995). Rewards and advancements for clinical pharmacy practitioners. Journal of Media Literacy Education. 2 indexed citations
17.
Welty, Timothy E., et al.. (1994). Impact of Vancomycin Therapeutic Drug Monitoring on Patient Care. Annals of Pharmacotherapy. 28(12). 1335–1339. 70 indexed citations
18.
Welty, Timothy E., et al.. (1992). Loss of Seizure Control Associated with Generic Substitution of Carbamazepine. Annals of Pharmacotherapy. 26(6). 775–777. 45 indexed citations
19.
Brundage, Richard C., James C. Cloyd, E. E. Leppik, Nina M. Graves, & Timothy E. Welty. (1987). Effect of Progabide on Serum Phenytoin and Carbamazepine Concentrations. Clinical Neuropharmacology. 10(6). 545–554. 3 indexed citations
20.
Mayer, Philip R., et al.. (1986). Intramuscular Tobramycin Pharmacokinetics in Geriatric Patients. Drug Intelligence & Clinical Pharmacy. 20(7-8). 611–615. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael E. Pitterle Breakdown of academic impact, for papers by Ida Fortino Breakdown of academic impact, for papers by M. Feely Breakdown of academic impact, for papers by Geneviève Durrieu Breakdown of academic impact, for papers by Reginald P. Sequeira Breakdown of academic impact, for papers by Thilo Bertsche Breakdown of academic impact, for papers by Branislava Miljković Breakdown of academic impact, for papers by B.‐E. Wiholm Breakdown of academic impact, for papers by Leonardo Régis Leira Pereira Breakdown of academic impact, for papers by Jordan R. Covvey
Rankless by CCL
2026